Kyushu University Hospital

A vizsgálati regiszterek ezeken a neveken tartják nyilván az intézményt. Minden sor egy regiszterbejegyzés: a címe és az alatta nyilvántartott vizsgálatok.

• Kyushu University Hospital

  Fukuoka, 812-8582

  140 vizsgálat

• Kyushu University Hospital

  Fukuoka, Fukuoka, 812-8582

  13 vizsgálat

• Kyushu University Hospital

  Higashiku, Fukuoka 812-8582

  3 vizsgálat

  • NCT04031677Surgery With or Without Neoadjuvant Chemotherapy in High Risk RetroPeritoneal Sarcoma

    Contact: EORTC HQ

  • NCT03155191Study of TBI-1501 for Relapsed or Refractory Acute Lymphoblastic Leukemia

  • NCT02960022A Study for Subjects With Prostate Cancer Who Previously Participated in an Enzalutamide Clinical Study

• Kyushu University Hospital (Site 2105)

  Fukuoka, 812-8582

  2 vizsgálat

  • NCT06925750A Clinical Study of Sotatercept (MK-7962) in People With Pulmonary Arterial Hypertension (MK-7962-031/LIGHTRAY EXTENSION)

  • NCT06664801A Clinical Study of Sotatercept (MK-7962) in People With Pulmonary Arterial Hypertension (PAH) (MK-7962-024)

• Kyushu University Hospital (Site 5005)

  Fukuoka, 812-8582

  2 vizsgálat

  • NCT04736706A Study of Pembrolizumab (MK-3475) in Combination With Belzutifan (MK-6482) and Lenvatinib (MK-7902), or Pembrolizumab/Quavonlimab (MK-1308A) in Combination With Lenvatinib, Versus Pembrolizumab and Lenvatinib, for Treatment of Advanced Clear Cell Renal Cell Carcinoma (MK-6482-012)

  • NCT04586231A Study of Belzutifan (MK-6482) in Combination With Lenvatinib Versus Cabozantinib for Treatment of Renal Cell Carcinoma (MK-6482-011)

• Kyushu University Hospital

  Higashi-ku, Fukuoka-city, Fukuoka, 8128582

  1 vizsgálat

  • NCT06465953Ivosidenib (IVO) Monotherapy and Azacitidine (AZA) Monotherapy in Patients With Hypomethylating Agent (HMA) Naive Myelodysplastic Syndromes (MDS) With an IDH1 Mutation

    Contact: Institut de Recherches Internationales Servier (I.R.I.S.), Clinical Studies Department

• Kyushu University Hospital_Endocrine Metab Diab inter med

  Fukuoka-shi, Fukuoka, 812-8582

  1 vizsgálat

  • NCT06283667Special Use - Results Surveillance on Long-term Use With Wegovy®

• Kyushu University Hospital(Gastrointestinal Surgery)

  Fukuoka, Fukuoka

  1 vizsgálat

  • NCT06901531A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer

    Contact: Astellas Pharma Global Development Inc.

• Kyushu University Hospital - Hematology/Oncology

  Fukuoka

  1 vizsgálat

  • NCT05257083A Study of Daratumumab, Bortezomib, Lenalidomide and Dexamethasone (DVRd) Followed by Ciltacabtagene Autoleucel Versus Daratumumab, Bortezomib, Lenalidomide and Dexamethasone (DVRd) Followed by Autologous Stem Cell Transplant (ASCT) in Participants With Newly Diagnosed Multiple Myeloma

• Kyushu University Hospital (Hematology, Oncology & Cardiovascular medicine)

  Fukuoka, Fukuoka

  1 vizsgálat

  • NCT06901531A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer

    Contact: Astellas Pharma Global Development Inc.

• Kyushu University Hospital /ID# 152525

  Fukuoka, Fukuoka 812-8582

  1 vizsgálat

  • NCT03006068A Study to Evaluate the Long-Term Safety and Efficacy of Upadacitinib (ABT-494) in Participants With Ulcerative Colitis (UC)

• Kyushu University Hospital /ID# 159688

  Fukuoka, Fukuoka 812-8582

  1 vizsgálat

  • NCT03069352A Study of Venetoclax in Combination With Low Dose Cytarabine Versus Low Dose Cytarabine Alone in Treatment Naive Patients With Acute Myeloid Leukemia Who Are Ineligible for Intensive Chemotherapy

• Kyushu University Hospital /ID# 169095

  Fukuoka, Fukuoka 812-8582

  1 vizsgálat

  • NCT02993523A Study of Venetoclax in Combination With Azacitidine Versus Azacitidine in Treatment Naïve Participants With Acute Myeloid Leukemia Who Are Ineligible for Standard Induction Therapy

• Kyushu University Hospital /ID# 171117

  Fukuoka, Fukuoka 812-8582

  1 vizsgálat

  • NCT03539744A Study Designed to Evaluate the Safety and Efficacy of Venetoclax Plus Dexamethasone (VenDex) Compared With Pomalidomide Plus Dexamethasone (PomDex) in Participants With t(11;14)-Positive Relapsed or Refractory Multiple Myeloma.

• Kyushu University Hospital /ID# 215286

  Fukuoka, Fukuoka 812-8582

  1 vizsgálat

  • NCT04102020A Study of Oral Venetoclax Tablets and Oral Azacitidine as Maintenance Therapy in Adult Participants With Acute Myeloid Leukemia in First Remission After Conventional Chemotherapy

• Kyushu University Hospital /ID# 221606

  Fukuoka, Fukuoka 812-8582

  1 vizsgálat

  • NCT04468984Study of Oral Navitoclax Tablet in Combination With Oral Ruxolitinib Tablet Versus Best Available Therapy to Assess Change in Spleen Volume in Adult Participants With Relapsed/Refractory Myelofibrosis

• Kyushu University Hospital /ID# 221783

  Fukuoka, Fukuoka 812-8582

  1 vizsgálat

  • NCT04472598Study of Oral Navitoclax Tablet In Combination With Oral Ruxolitinib Tablet When Compared With Oral Ruxolitinib Tablet To Assess Change In Spleen Volume In Adult Participants With Myelofibrosis

• Kyushu University Hospital /ID# 222691

  Fukuoka, Fukuoka 812-8582

  1 vizsgálat

  • NCT03222609A Study Evaluating Tolerability and Efficacy of Navitoclax Alone or in Combination With Ruxolitinib in Participants With Myelofibrosis

• Kyushu University Hospital /ID# 223299

  Fukuoka, Fukuoka 812-8582

  1 vizsgálat

  • NCT04477486Study to Assess Effect of Oral Venetoclax Tablet in Combination With Oral Ibrutinib Capsule on Best Overall Response of Complete Response in Adult Japanese Participants With Relapsed/Refractory Mantle Cell Lymphoma

• Kyushu University Hospital /ID# 223473

  Fukuoka, Fukuoka 812-8582

  1 vizsgálat

  • NCT04401748Study Of Venetoclax Tablet With Intravenous or Subcutaneous Azacitidine to Assess Change in Disease Activity In Adult Participants With Newly Diagnosed Higher-Risk Myelodysplastic Syndrome

• Kyushu University Hospital /ID# 226091

  Fukuoka, Fukuoka 812-8582

  1 vizsgálat

  • NCT05578976A Study to Evaluate Change in Disease Activity of Subcutaneous (SC) Epcoritamab Combined With Intravenous and Oral Rituximab, Cyclophosphamide, Doxorubicin Hydrochloride, Vincristine, and Prednisone (R-CHOP) or R-CHOP in Adult Participants With Newly Diagnosed Diffuse Large B-Cell Lymphoma (DLBCL)

• Kyushu University Hospital /ID# 226734

  Fukuoka, Fukuoka 812-8582

  1 vizsgálat

  • NCT04340115Study To Assess Frequency Of Serious Infections In Clinical Practice In Japan For Adult Participants With Rheumatoid Arthritis Receiving Oral RINVOQ Tablets

• Kyushu University Hospital /ID# 228035

  Fukuoka, Fukuoka 812-8582

  1 vizsgálat

  • NCT04454658Safety and Tolerability Study of Oral ABBV-744 Tablet Alone or in Combination With Oral Ruxolitinib Tablet or Oral Navitoclax Tablet in Adult Participants With Myelofibrosis

• Kyushu University Hospital /ID# 230136

  Fukuoka, Fukuoka 812-8582

  1 vizsgálat

  • NCT05409066Study of Subcutaneous Epcoritamab in Combination With Intravenous Rituximab and Oral Lenalidomide (R2) to Assess Adverse Events and Change in Disease Activity in Adult Participants With Follicular Lymphoma

• Kyushu University Hospital /ID# 232147

  Fukuoka, Fukuoka 812-8582

  1 vizsgálat

  • NCT04340115Study To Assess Frequency Of Serious Infections In Clinical Practice In Japan For Adult Participants With Rheumatoid Arthritis Receiving Oral RINVOQ Tablets

• Kyushu University Hospital /ID# 238437

  Fukuoka, Fukuoka 812-8582

  1 vizsgálat

  • NCT05105841Study to Assess Change in Disease Activity and Adverse Events of Oral Venetoclax in Combination With Intravenous (IV) Obinutuzumab or Oral Ibrutinib in Adult Participants With Untreated Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)

• Kyushu University Hospital /ID# 248781

  Fukuoka, Fukuoka 812-8582

  1 vizsgálat

  • NCT04813263Study of Oral Venetoclax Tablets to Evaluate Adverse Events and Change in Disease Activity in Participants of Any Age With Acute Myeloid Leukemia

• Kyushu University Hospital /ID# 261351

  Fukuoka, Fukuoka 812-8582

  1 vizsgálat

  • NCT04214028A Study of the Safety, Effectiveness and Clinical Use of Maviret in Adolescent Patients With Chronic Hepatitis C Virus

• Kyushu University Hospital /ID# 264704

  Fukuoka, Fukuoka 812-8582

  1 vizsgálat

  • NCT06158841Study Assessing Activity of Intravenous (IV) Etentamig Monotherapy Versus Standard Available Therapies in Adult Participants With Relapsed or Refractory Multiple Myeloma

• Kyushu University Hospital /ID# 266100

  Fukuoka, Fukuoka 812-8582

  1 vizsgálat

  • NCT05930275Study to Assess Speed of Onset and Durability of Effectiveness of Upadacitinib in Adult Participants With Moderate to Severe Crohn's Disease (CD) in Real World Clinical Practice.

• Kyushu University Hospital /ID# 267624

  Fukuoka, Fukuoka 812-8582

  1 vizsgálat

  • NCT06508658A Study of Subcutaneously Injected Epcoritamab Plus Oral Lenalidomide Tablets Compared to Intravenously (IV) Infused Rituximab Plus IV Infused Gemcitabine and IV Infused Oxaliplatin in Adult Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma

• Kyushu University Hospital /ID# 267861

  Fukuoka, Fukuoka 812-8582

  1 vizsgálat

  • NCT06191744Study of Subcutaneous Epcoritamab in Combination With Intravenous Rituximab and Oral Lenalidomide (R2) to Assess Adverse Events and Change in Disease Activity in Adult Participants With Previously Untreated Follicular Lymphoma

• Kyushu University Hospital /ID# 273710

  Fukuoka, Fukuoka 812-8582

  1 vizsgálat

  • NCT07023289A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease

• Kyushu University Hospital /ID# 276302

  Fukuoka, Fukuoka 812-8582

  1 vizsgálat

  • NCT07196644A Study to Assess Adverse Events and Change in Disease Activity in Participants 12 Years of Age or Older With Locally Advanced or Metastatic Solid Tumors That Harbor MET Amplification Receiving Intravenously Infused Telisotuzumab Adizutecan

• Kyushu University Hospital /ID# 278077

  Fukuoka, Fukuoka 812-8582

  1 vizsgálat

  • NCT07136116Study to Assess Change in Disease Activity of Risankizumab Treatment in Japanese Participants With Moderate to Severe Ulcerative Colitis

    Contact: AbbVie GK Clinical Trial Registration Desk

• Kyushu University Hospital /ID# 279964

  Fukuoka, Fukuoka 812-8582

  1 vizsgálat

  • NCT07365241A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer

• Kyushu University Hospital (KUH) - Site #703

  Fukuoka, 812-8582

  1 vizsgálat

  • NCT05248646Trial of Sibeprenlimab in the Treatment of A Nephropathy (IgAN)

• Kyushu university hospital_Pediatrics

  Fukuoka, 812-8582

  1 vizsgálat

  • NCT06285071Post-Marketing Surveillance (All Case Surveillance) on Treatment With Alhemo® in Patients With Haemophilia A or Haemophilia B With Inhibitors

• Kyushu University Hospital (Site 0008)

  Fukuoka, 812-8582

  1 vizsgálat

  • NCT04317066A Study of Pembrolizumab (MK-3475) in Participants With Relapsed or Refractory Primary Mediastinal Large B-cell Lymphoma (rrPMBCL) (MK-3475-A33/KEYNOTE-A33)

• Kyushu University Hospital (Site 0010)

  Fukuoka, 812-8582

  1 vizsgálat

  • NCT05609968Study of Pembrolizumab (MK-3475) Monotherapy Versus Sacituzumab Govitecan in Combination With Pembrolizumab for Participants With Metastatic Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥50% (MK-3475-D46)

• Kyushu University Hospital (Site 0030)

  Fukuoka, 812-8582

  1 vizsgálat

  • NCT03829332Efficacy and Safety Study of Pembrolizumab (MK-3475) With or Without Lenvatinib (MK-7902/E7080) in Adults With Programmed Cell Death-Ligand 1 (PD-L1)-Positive Treatment-naïve Nonsmall Cell Lung Cancer (NSCLC) (MK-7902-007/E7080-G000-314/LEAP-007)

• Kyushu University Hospital (Site 0173)

  Fukuoka, 812-8582

  1 vizsgálat

  • NCT03221426Study of Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy in Participants With Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (MK-3475-585/KEYNOTE-585)

• Kyushu University Hospital (Site 0413)

  Fukuoka, 812-8582

  1 vizsgálat

  • NCT03142334Safety and Efficacy Study of Pembrolizumab (MK-3475) as Monotherapy in the Adjuvant Treatment of Renal Cell Carcinoma Post Nephrectomy (MK-3475-564/KEYNOTE-564)

• Kyushu University Hospital (Site 0434)

  Fukuoka, 812-8582

  1 vizsgálat

  • NCT07419295A Clinical Trial of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) to Treat Urothelial Cancer (MK-2870-031)

    Contact: Study Coordinator

• Kyushu University Hospital (Site 0605)

  Fukuoka, 812-8582

  1 vizsgálat

  • NCT06456346Bomedemstat vs Hydroxyurea for Essential Thrombocythemia (MK-3543-007)

• Kyushu University Hospital (Site 0718)

  Fukuoka, 812-8582

  1 vizsgálat

  • NCT03834519Study of Pembrolizumab (MK-3475) Plus Olaparib Versus Abiraterone Acetate or Enzalutamide in Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-7339-010/KEYLYNK-010)

• Kyushu University Hospital (Site 0745)

  Fukuoka, 812-8582

  1 vizsgálat

  • NCT06136650A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)

    Contact: Study Coordinator

• Kyushu University Hospital (Site 0862)

  Fukuoka, 812-8582

  1 vizsgálat

  • NCT06997497A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012)

    Contact: Study Coordinator

• Kyushu University Hospital (Site 0919)

  Fukuoka, 812-8582

  1 vizsgálat

  • NCT06136624Study of Opevesostat (MK-5684) Versus Alternative NHA in mCRPC (MK-5684-003)

    Contact: Study Coordinator

• Kyushu University Hospital (Site 1007)

  Fukuoka, 812-8582

  1 vizsgálat

  • NCT04195750A Study of Belzutifan (MK-6482) Versus Everolimus in Participants With Advanced Renal Cell Carcinoma (MK-6482-005)

• Kyushu University Hospital (Site 1105)

  Fukuoka, 812-8582

  1 vizsgálat

  • NCT05458297A Study of Zilovertamab Vedotin (MK-2140) as Monotherapy and in Combination in Participants With Aggressive and Indolent B-cell Malignancies (MK-2140-006)

• Kyushu University Hospital (Site 1204)

  Fukuoka, 812-8582

  1 vizsgálat

  • NCT06353386Substudy 01A: Safety and Efficacy of Opevesostat (MK-5684)-Based Treatment Combinations or Opevesostat Alone in Participants With Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-5684-01A)

• Kyushu University Hospital (Site 1515)

  Fukuoka, 812-8582

  1 vizsgálat

  • NCT06925737A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)

    Contact: Study Coordinator

• Kyushu University Hospital (Site 1715)

  Fukuoka, 812-8582

  1 vizsgálat

  • NCT05239728A Study of Belzutifan (MK-6482) Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants With Clear Cell Renal Cell Carcinoma Post Nephrectomy (MK-6482-022)

• Kyushu University Hospital (Site 1813)

  Fukuoka, 812-8582

  1 vizsgálat

  • NCT04924075Belzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreatic Neuroendocrine Tumor (pNET), Von Hippel-Lindau (VHL) Disease-Associated Tumors, Advanced Gastrointestinal Stromal Tumor (wt GIST), or Solid Tumors With HIF-2α Related Genetic Alterations (MK-6482-015)

    Contact: Study Coordinator

• Kyushu University Hospital (Site 1914)

  Fukuoka, 812-8582

  1 vizsgálat

  • NCT06136559A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1026-011/BELLWAVE-011)

    Contact: Toll Free Number

• Kyushu University Hospital (Site 2015)

  Fukuoka, 812-8582

  1 vizsgálat

  • NCT05818137A Study of Sotatercept in Japanese Pulmonary Arterial Hypertension (PAH) Participants (MK-7962-020)

• Kyushu University Hospital (Site 3313)

  Fukuoka, 812-8582

  1 vizsgálat

  • NCT06717347A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010)

    Contact: Study Coordinator

• Kyushu University Hospital (Site 3400)

  Fukuoka, 812-8582

  1 vizsgálat

  • NCT06305754Sacituzumab Tirumotecan (MK-2870) Versus Pemetrexed and Carboplatin Combination Therapy in Participants With Epidermal Growth Factor (EGFR)-Mutated, Advanced Nonsquamous Non-small Cell Lung Cancer (NSCLC) Who Have Progressed on Prior EGFR Tyrosine Kinase Inhibitors (MK-2870-009)

• Kyushu University Hospital (Site 3407)

  Fukuoka, 812-8582

  1 vizsgálat

  • NCT06074588Sacituzumab Tirumotecan (MK-2870) Versus Chemotherapy in Previously Treated Advanced or Metastatic Nonsquamous Non-small Cell Lung Cancer (NSCLC) With EGFR Mutations or Other Genomic Alterations (MK-2870-004)

• Kyushu University Hospital (Site 3605)

  Fukuoka, 812-8582

  1 vizsgálat

  • NCT06079879A Study of Bomedemstat (IMG-7289/MK-3543) Compared to Best Available Therapy (BAT) in Participants With Essential Thrombocythemia and an Inadequate Response or Intolerance of Hydroxyurea (MK-3543-006)

• Kyushu University Hospital (Site 5129)

  Fukuoka, 812-8582

  1 vizsgálat

  • NCT06841354A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Triple-Negative Breast Cancer (MK-2870-011/TroFuse-011)

    Contact: Study Coordinator

• Kyushu University Hospital (Site 9010)

  Fukuoka, 812-8582

  1 vizsgálat

  • NCT07033494A Clinical Study of MK-2214 in People With Early Alzheimer's Disease (MK-2214-004)

    Contact: Study Coordinator